Atlas Trials

Refractory Waldenstrom Macroglobulinemia

7 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Waldenstrom Macroglobulinemia

RecordFirmDate
Ibrutinib and Ixazomib Citrate in Treating Newly Diagnosed, Relapsed or Refractory Waldenstrom Macroglobulinemia (NCT03506373)Mayo Clinic2018-08-14
Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas (NCT02332980)Mayo Clinic2015-02-19
Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (NCT01198067)M.D. Anderson Cancer Center2010-10-06

Track Refractory Waldenstrom Macroglobulinemia automatically

Every clearance here is in the API, with alerts when new ones post.